$TEVA

$AMD Feb24 80 P $TEVA Jan-24 7 P $PYPL Mar 75 P $SI Mar 17.5 P $CAG Feb24 35 P $IGT Apr 25 P $CWH Feb24 26.5 P

$AMD Feb24 80 P $TEVA Jan-24 7 P $PYPL Mar 75 P $SI Mar 17.5 P $CAG Feb24 35 P $IGT Apr 25 P $CWH Feb24 26.5 P

$SQ Jan27 90 C $NIO Mar 12.5 C $IGT Mar 26 C $PARA Feb10 21.5 C $CZR Feb03 50 C $LU Feb 3 C $FTCH Jan27 6.5 C $TXN Mar 190 C $ROKU Feb03 57 C $MSFT Jan27 260/265 C S $ONON Jul 25 C $ATVI Jun 95 C $TXN Mar 190 C $LILAK Apr 10 C $TEVA Jan024 12 C $EWY Feb 69 C $CVS Mar 95 C $OKE Mar 75 C $ARKK Jan27 40 C

$SQ Jan27 90 C $NIO Mar 12.5 C $IGT Mar 26 C $PARA Feb10 21.5 C $CZR Feb03 50 C $LU Feb 3 C $FTCH Jan27 6.5 C $TXN Mar 190 C $ROKU Feb03 57 C $MSFT Jan27 260/265 C S $ONON Jul 25 C $ATVI Jun 95 C $TXN Mar 190 C $LILAK Apr 10 C $TEVA Jan024 12 C $EWY Feb 69 C $CVS Mar 95 C $OKE Mar 75 C $ARKK Jan27 40 C

holding $TEVA to 12

have runner teva close above 11.2 is nice

$TEVA up 18% since uoa

$TEVA out of box

$BILI Apr 40 C $PLUG Jan06 13.5 C $WFC Jan06 43 C $AMZN Jan 110 C $MLCO Jan 14 C $TEVA Jan06 9.5 C $TEVA Jan13 10 C $LYFT Jan 12.5/15 C Spd $GRAB Feb 3.5 C

RECAP 1/3 Unusual Calls: $BILI Apr 40 C $PLUG Jan06 13.5 C $WFC Jan06 43 C $AMZN Jan 110 C $MLCO Jan 14 C $TEVA Jan06 9.5 C $TEVA Jan13 10 C $LYFT Jan 12.5/15 C Spd $GRAB Feb 3.5 C

$teva Outperform today lol of course

$TEVA - Bullish option flow detected in Teva (9.29 +0.43) with 12,705 calls trading (3x expected) and implied vol increasing over 3 points to 39.97%. . The Put/Call Ratio is 0.23. Earnings are expected on 02/08. The JAN 2023 10.00 Calls are active.

RECAP 9/29 Unusual Puts: $AAPL Oct07 135 P $GM Oct 33 P $MPW Oct 12 P $TEVA Jun 6 P $AAPL Oct28 125 P

$AAPL Oct07 135 P $GM Oct 33 P $MPW Oct 12 P $TEVA Jun 6 P $AAPL Oct28 125 P

RECAP 8/16 Unusual Calls: $FUBO Aug 5 C $TSLA Sep02 980 C $KWEB Nov 40 C $AFRM Aug 38 C $WBD Sep 15 C $TEVA Dec 14 C $BBBY Jan 80 C $BBBY Aug 45 C $BAC Jan 40 C $VRM Sep 3 C $EMB Aug 90 C $SQ Sep 85 C $DB Oct 10 C

RECAP 8/4 Unusual Calls: $MQ Sep 10 C $TEVA Jan 12 C $NFLX Sep 260 C $HST Aug 18 C $GBT Sep 50 C $OPEN Aug05 5 C RECAP 8/4 Unusual Puts: $CNQ Dec 50 P $WFC Jan-24 42.5 P $GERN Jan1 P

$TEVA $ABBV Iowa attorney general says if finalized, allergan settlement, with teva settlement announced this week, would provide as much as $6.6 bln nationwide

**@CNBC:** Florida reaches $878 million opioid settlements with CVS, Teva, others https://t.co/P9XFoh82fq https://twitter.com/CNBC/status/1509197132804276232

it appears a lawsuit against the companies by the state of california didnt go california's way and the result could lead to a nationwide settlement for not just TEVA but a load of pharma companies. If so this thing could be producing earnings of $3 a share in 1-2 years. Any DCF model would give this a $30/$40 price i would think. Certainly overtime

looking at TEVA. This seems a value play. Its trading at 3.2 x next years earnings. It had a load of opoid lawsuits but as i understand it these are coming to an end. Huge increase in OI last week in Spt $15 and Sept $10 calls. bERSHIRE THERE BIGGEST SHAREHOLDER..... has massive volume in the base here..... the longer the base, the higher in space might be the appropriate motto for this one

see the news there is some inmportant stuff in there mainly $JNJ and $TSLA as well as $TEVA

U.S. futures are holding steady, only moderately lower from yesterday’s closing all-time highs for the major averages as investors brace for the FOMC meeting, with results expected tomorrow afternoon. Bitcoin prices surging to highs, up over 4% around $63,400 in another broad spike for crypto assets; Ethereum +3.25% at $4,450. House Speaker Pelosi is planning to go ahead with plans to vote this week on President Biden’s two bills even though Democratic moderates are echoing Senator Manchin’s complaints that they don’t know full cost & economic impact. In corporate news, JNJ, TEVA, ENDP and ABBV win the first case for pharmaceutical companies in the four-year litigation over the drugs in a $50B opioid litigation case. In commodity prices, gold holds below $1,800, oil is little changed around $84 per barrel and Wheat hit $8.00 a bushel Monday, highest levels since 2012 as world reserves declined following extreme weather. The Aussie dollar drops and the curve bull steepens after the RBA scraps its April 2024 yield target and signals openness to earlier rate hikes. Tesla $TSLA falls over 4%, is falling off a record high close of $1,208.59 – follows tweet from CEO Musk overnight saying there has been no contract signed yet with Hertz and that the Hertz deal has zero effect on Tesla’s economic. Wall Street’s main indexes notched record closing highs again on Monday, adding to the big totals in October as Tesla $TSLA shares surged and the energy sector gained on rising oil prices while investors looked ahead to a major Federal Reserve meeting later in the week. The Dow Jones Industrial Average briefly eclipsed 36,000 points for the first time before slipping just below. Along with the barrage of earnings again this week, the Federal Reserve is expected to approve plans to scale back its $120 billion monthly bond-buying program on Wednesday. The small-cap Russell 2000 index was a standout, rising 2.7% for its biggest daily percentage gain since late August. Economic data was mixed as the ISM U.S. manufacturing activity slowed in October, with all industries reporting record-long lead times. In Asian markets, The Nikkei Index slipped -0.43% to 29,520, the Shanghai Index dropped -1.1% to 3,505, and the Hang Seng Index fell -0.22% to 25,099. In Europe, the German DAX is up +0.4% at 15,875, while the FTSE 100 declines around -0.6% below 7,250. Events Calendar for Today · 7:45 AM ET ICSC Weekly Retail Sales · 8:55 AM ET Johnson/Redbook Weekly Sales Earnings Calendar: · Earnings Before the Open: AME, APO, ARCB, AVNS, BBGI, BCC, BHC, BLD, BLMN, CEIX, CLW, CMI, COP, CRSR, CTLT, DD, EL, EPD, ESPR, ETN, EXLS, EXPD, EXTR, GNRC, GPN, HEES, HEP, HSC, HSIC, IART, IDXX, INCY, IPGP, IT, KKR, LCII, LDOS, LEA, LGIH, LPX, MIME, MLM, MMP, MPC, MPLX, MYGN, NRZ, NXST, NYMT, OMCL, PFE, PINC, RL, ROK, SABR, SAGE, SEE, TMX, TNC, UAA, VAL, WEC, WLK, XHR, XYL ZBRA · Earnings After the Close: ACT, AFG, AIZ, AKAM AMGN, ANDE, ATVI, AWK, AYX, BFAM, BGFV, BKH, BRY, BXC, CASA, CDK, CERS, CHK, COUR, CRK, CSLT, CZR, DCO, DCPH, DEI, DENN, DOX, DRRX, DVN, EGHT, EIX, ENLC, EXAS, EXEL, FMC, FNF, FRSH, GAIN, GNW, GPOR, HALO, HCC, HLF, HRB, HURN, INFI, INSP, KAI, KAMN, KAR, LPI, LSCC, LSI, LYFT, MANT, MDLZ, MG, MGNX, MOD, MRCY, MTCH, NP, NSA, OKE, OVV, PAA, PAGP, PAYC, PKI, PRO, PRTS, PRU, RAMP, RARE, RCKY, RM, RRR, SGRY, SKY, SRC, STE, TCS, TMUS, TVTY, UIS, UNM, VECO, VOYA, VRSK, WTTR, WU, ZG Other Key Events: · China Caixin Services PMI for October · Wolfe Research Wealth Symposium, 11/2-11/3 $virtual · Senator Manchin says he is prepared to support a Build Back Better plan that combats inflation, is fiscally responsible, and will create jobs. The plan the House is finalizing meets those tests-it is fully paid for, will reduce the deficit, and brings down costs for health care, child care, elder care, and housing

Friday, October 29, 2021 Futures Up/Down % Last Dow -45.00 0.13% 35,568 S&P 500 -22.25 0.49% 4,565 Nasdaq -139.50 0.88% 15,625 After trading to all-time highs Thursday for the S&P 500, Dow Jones, and Nasdaq Composite (and a 2% gain for the Russell 2000 as well) on strong earnings as well as positive developments on the spending bill in Washington, futures are pulling back. Shares of tech and retail giants Apple (AAPL) and Amazon (AMZN) are lower by 3% and 4% respectively after AAPL’s iPhone and overall revs miss for the quarter and AMZN drops on a Q3 revs miss, lower op income and lower guidance, sending Nasdaq Futures lower by about 1%. Investor sentiment is also starting to turn cautious amid the steady stream of corporate warnings on inflationary pressures and supply chain woes. Big day of inflation data with the personal spending and income for Sept and PCE inflation data expected at 8:30 AM. The 10-year Treasury yield is up around 1.61%, recovering off mid-week lows around the mid 1.5% level. Bitcoin prices are lower holding around the $60K level while oil futures are on track to snap their 8-week winning streak. In Asian markets, The Nikkei Index rises 0.25% to 28,890, the Shanghai Index gains 0.8% to 3,547, and the Hang Seng Index falls =0.7% to 25,377. In Europe, the German DAX is lower -1.2% to 15,500, while the FTSE 100 down -0.5% at 7,210. Market Closing Prices Yesterday The S&P 500 Index gained 44.74 points, or 0.98%, to 4,596.42 The Dow Jones Industrial Average rose 239.79 points, or 0.68%, to 35,730.48 The Nasdaq Composite surged 212.28 points, or 1.39%, to 15,448.12 The Russell 2000 Index advanced 45.49 points, or 2.02% to 2,297.98 Events Calendar for Today 8:30 AM ET Personal Income for September…est. (-0.2%) 8:30 AM ET Personal Spending for September…prior +0.4% 8:30 AM ET PCE Price Index MoM for September 8:30 AM ET PCE Price Index YoY for September 8:30 AM ET Core PCE Price Index MoM for September…est. +0.2% 8:30 AM ET Core PCE Price Index YoY for September…est. +3.7% 9:45 AM ET Chicago PMI for October…est. 63.5 (prior 64.7) 10:00 AM ET University of Michigan Confidence, Oct-F…est. 71.4 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: ABBV, AON, B, BAH, CERN, CHD, CHTR, CL, COWN, CVX, DCOM, HUN, IRMD, LHX, PIPR, POR, PSX, PSXP, RUTH, WY, XOM Macro Up/Down Last Nymex 0.34 83.15 Brent 0.37 84.69 Gold -2.95 1,795.95 EUR/USD -0.0029 1.1652 JPY/USD 0.19 113.76 10-Year Note +0.041 1.61% Sector News Breakdown Consumer com (AMZN) shares fall -3%; 3Q EPS $6.12 vs est. $8.92 on sales $110.8B vs est. $111.6B, AWS net sales $16.11B; guides 4Q sales $130-140B vs est. $142B; sees q4 operating income is expected to be between $0 and $3.0 bln, compared with $6.9 bln in q4 2020; in q4, expect to incur several bln dollars of additional costs in consumer business as we manage through labor supply shortages Starbucks (SBUX) Q4 EPS $1.00 vs. est. $0.99; Q4 revs rose 31% to $8.1B vs. est. $8.21B; commits to $20 bln of share repurchases and dividends over next three years; qtrly active Starbucks rewards membership in U.S. approaches 25 mln, up 28% YoY; qtrly comp store sales of 17% globally; qtrly international comp store sales grew 3%; qtrly comp store sales of 22% in U.S.; comp store sales decreased 7% in China Columbia Sportswear (COLM) 3Q EPS $1.52 vs est. $1.33 on revs $804.7Mm vs est. $862Mm; qtrly inventory -7%; guides FY net sales +21.5-23% vs prior +25-26.5% and est. +26.5%, sees FY EPS $4.55-4.80 vs est. $4.65; says believe can achieve mid-teens or better net sales growth in 2022 vs est. +10% Decker’s Outdoors (DECK) 2Q EPS $3.66 vs est. $4.00 on sales $721.9Mm vs est. $765.9Mm, comps +1%; sees FY EPS $14.15-15.15 vs est. $15.15; Gross margin was 50.9% compared to 51.2% for the same period last year; Decker’s also said: UGG(R) brand net sales for the second quarter increased 8.0% to $448.4 million compared to $415.1 million for the same period last year. HOKA(R) brand net sales for the second quarter increased 47.0% to $210.4 million compared to $143.1 million for the same period last year. Teva(R) brand net sales for the second quarter increased 4.0% to $28.8 million compared to $27.7 million for the same period last year. Frontdoor (FTDR) 3Q EPS $0.89 vs est. $0.68 on revs $471Mm vs est. $476.5Mm; guides 4Q revs $330-340Mm vs est. $347.7Mm, sees FY revs $1.59-1.6B vs est. $1.62B Mohawk Industries (MHK) Q3 adj EPS $3.95 vs. est. $3.81; Q3 revs $2.817B vs. est. $2.9B; guides Q4 EPS $2.80-$2.90 vs. est. $3.23 Skecher’s (SKX) Q3 EPS $0.66 vs. est. $0.73; Q3 sales rose 19.2% to $1.55B vs. est. $1.63B; guides Q4 EPS $0.28-$0.33 vs. est. $0.34 and year EPS view cut to $2.45-$2.50 from $2.55-$2.65; cuts FY21 revenue view to $6.15B-$6.2B from $6.15B-$6.25B; Direct-to-Consumer sales grew 44.1% and wholesale sales grew 10.5% SkyWest (SKYW) 3Q adj EPS $1.45 vs est. $0.70 on revs $745Mm vs est. $687.7Mm; says experienced a severe outage in October resulting in about 1,700 flight cancelations and expect may impact 4Q results from $15-20Mm pre-tax; Texas Roadhouse (TXRH) Q3 EPS $0.75 vs est. $0.81 on revenue $869.9M vs est. $869.4M; comp sales +30.2% vs 3Q20, +22.3% vs 2019, partially offset by higher food/beverage costs with commodity inflation 13.9% driven by higher beef prices; sees positive comp sales in FY22, commodity cost inflation in high-teens in 1H22 Energy Chevron (CVX) Q3 adj EPS $2.96 vs. est. $2.21; Q3 revs $43B vs. est. $40.52B; posted net income of $6.11B vs. a loss of $207M a year ago; said Q3 average sales price per barrel of crude oil and natural gas liquids was $58, vs $31 a year earlier Dril-Quip (DRQ) 3Q EPS ($0.31) vs est. ($0.14) on revs $83Mm vs est. $85.6Mm, sees 4Q bookings at high end of $40-60Mm range (unchanged from prior view) First Energy (FE) Q3 adj EPS $0.82 vs. est. $0.79; Q3 revs $3.1B in-line with ests; raises FY21 adj EPS view to $2.55-$2.65 from $2.40-$2.60 (est. $2.54) SM Energy (SM) Q3 EPS $0.69 vs. est. $0.13; Q3 revs $760.24M vs. est. $510.61M; Q3 Production was 14.3 MMBoe (155.8 MBoe/d) and was 56% oil; the Company is increasing guidance for 2021 production volumes to 49.5-50.0 MMBoe (135.6-137.0 MBoe/d) Financials Hartford Financial (HIG) Q3 core EPS $1.26 vs. est. $0.86; Net income ROE for the trailing 12-month period ended Sept. 30, 2021 was 12.3% and core earnings ROE* for the same period was 12.5%; the Commercial Lines combined ratio was 101.2 in third quarter 2021 with an underlying combined ratio* of 87.2, a 6.5-point improvement YoY LPL Financial (LPLA) Q3 EPS $1.77 vs est. $1.75 on revenue $2.02B vs est. $2.05B; total advisory and brokerage assets $1.13 trillion (+40% YoY), organic net new assets $27B (+10% annualized) in the qtr, $110B over past 12-months (+14% annualized) Riley Financial (RILY) announced a $4 dividend, composed of a $3 special one-time payout and a doubling of its regular quarterly dividend to $1 Healthcare 4D Molecular (FDMT)75M share Secondary priced at $25.00 AirSculpt Technologies (AIRS) 7M share IPO priced at $11.00 Aura Biosciences (AURA) 5M share IPO priced at $14.00 Entrada Therapeutics (TRDA)075M share IPO priced at $20.00 Sonendo (SONX)8M share IPO priced at $12.00 Valneva (VALN)5M share Secondary priced at $39.42 Acadia Healthcare (ACHC) Q3 adj EPS in-line at $0.72; Q3 revs $587.6M vs. est. $590.9M; Q3 same facility revenue increased 7.9% YoY, including an increase in revenue per patient day of 5.6% and an increase in patient days of 2.2%; same facility adjusted EBITDA margin was 29.0%; narrowed 2021 revenue to $2.295B-$2.315B vs. est. $2.31B CareDX (CDNA) Q3 adj EPS 7c vs est. 1c on revenue $75.6M vs est. $74M; raised FY21 revenue forecast to $290M-$293M from $280M-$290M DaVita Inc. (DVA) 3Q EPS $2.36 vs est. $2.25 on revs $2.94B, says US dialysis treatments averaged 94,509/day; guides FY adj EPS $8.80-9.15 vs est. $9.19 Dexcom (DXCM) Q3 EPS $0.71 vs. est. $0.63; Q3 revs $650.2M vs. est. $617.82; Based on the strong third quarter results, Dexcom is increasing its guidance for fiscal year 2021 revenue, Non-GAAP gross profit margin, Non-GAAP operating margin, and Adjusted EBITDA margin Gilead Sciences (GILD) 3Q adj EPS $2.65 vs est. $1.75 on revs $7.4B vs est. $6.3B; guides FY total product sales $26-26.3B vs est. $25.14B (sees $21.5B ex Veklury); guides FY adj EPS $7.90-8.10 vs est. $7.19 Nextgen health (NXGN) 2Q adj EPS $0.29 vs est. $0.23 on revs $149.3Mm vs est. $143.4Mm; guides FY revs $584-590Mm vs est. $582.4Mm, sees FY adj EPS $0.90-0.96 vs est. $0.93; says may repurchase up to $60Mm of its outstanding shares through March 2023 PTC Therapeutics (PTCT) Q3 EPS loss ($1.89) vs. est. loss ($1.40); Q3 revs $139M vs. est. $126.44M; raises FY21 rev view for DMD franchise to $400M-$420M from $370M-$390M and narrows R&D and SG&A expenses to $815M-$835M from $825M-$855M. ResMed (RMD) 1Q EPS $1.39 vs est. $1.36 on revs $904Mm vs est. $860.9Mm Seagen (SGEN) Q3 EPS ($1.61) vs est. $(0.58) on revenue $424.1M vs est. $383.1M, total net product sales $366.5M (+37% YoY) Stryker (SYK) Q3 adj EPS $2.20 vs. est. $2.28; Q3 revs $4.16B vs. est. $4.23B; Q3 organic net sales increased 4.5%; raises FY21 adjusted EPS view to $9.08-$9.15 from $8.80-$9.20 (est. $9.30); said now expect 2021 organic net sales growth to be in the range of 7% to 8% from 2019 Industrials & Materials Eastman Chemical (EMN) 3Q adj EPS $2.46 vs est. $2.46 on revs $2.72B vs est. $2.6B; guides FY EPS $8.80-9.00 vs est. $9.09, sees FY FCF about $1.1B; says implementing price increases across specialty product lines to offset higher costs, expect to be caught up in early 2022 Ecolab (ECL) to acquire Purolite, a leading global provider of fast-growing, high value separation and purification solutions to life sciences and critical industrial markets; Ecolab to pay approximately $3.7 billion in cash Fortive (FTV) Q3 adj EPS $0.66 vs. est. $0.65; Q3 revs $1.3B vs. est. $1.32B; raises FY21 adj EPS view to $2.70-$2.75 from $2.65-$2.75 (est. $2.72); said Delivered significant margin improvement, strong adjusted operating margin expansion and robust cash flow growth Hub Group (HUBG) Q3 EPS $1.28 vs est. $1.10 on in-line revs $1.08B; raises FY21 EPS $3.90-$4 from $3.50-$3.70 vs est. $3.66, still sees rev growth in the high-teens Huntington Ingalls (HII) 2Q adj EPS $1.71 vs est. $1.17 on revs $537Mm vs est. $375.6Mm L3Harris Technologies (LHX) raises FY21 adjusted EPS view to $12.85-$13.00 from $12.80-$13.00 and lowers FY21 revenue view to approximately $17.9B from $18.1B-$18.5B Mercer Int’l (MERC) 3Q EPS $1.04 vs est. $0.83 on revs $469.7Mm vs est. $452.9Mm Polymetal International PLC (POLY) 2Q adj EPS $0.77 vs est. $0.56 on revs $419Mm vs est. $428.4Mm; guides FY adj EPS $2.30-2.70 vs est. $3.10, sees FY revs $1.675-1.725B vs est. $1.8B Republic Service (RSG) 3Q adj EPS $1.11 vs est. $1.05 on revs $2.93B vs est. $2.84B; guides FY adj EPS $4.10-4.13 from prior $4.00-$4.05 and vs est. $4.05 Terex Corp. (TEX) 3Q EPS $0.67 vs est. $0.72 on sales $993.8Mm vs est. $1.0B; guides FY sales $3.85B vs est. $3.86B, sees FY EPS $2.75-2.85 vs est. $2.82 Werner Enterprise (WERN) Q3 EPS $0.94 vs. est. $0.95; Q3 revs $702.9M vs. est. $700.8M S. Steel (X) announces a $300 million stock repurchase program and increases its quarterly dividend to $0.05 per share; Q3 adjusted EPS $5.36 tops consensus $4.85; Q3 revs $5.96B vs. est. $5.79B

Wednesday, October 13, 2021 Futures Up/Down % Last Dow 34.00 0.10% 34,295 S&P 500 5.75 0.14% 4,346 Nasdaq 61.75 0.42% 14,715 U.S. futures recover from overnight losses ahead of Dow component JPMorgan earnings and inflation data later this morning (CPI), reversing overnight losses despite weakness in Dow component Apple (AAPL), which is down about -0.5% after reports it expects to make 10 million fewer iPhone than planned and is poised to slash iPhone production goal due to chip crunch. Oil prices and Treasury yields decline, while gold rises ahead of a key reading of consumer price September inflation. Futures are getting a boost after better economic data in China as September exports rose 28.1% from last year as consumer demand outpace supply chain disruptions and power shortages, while last night’s passage of a debt ceiling extension by House lawmakers puts at least one market concern to the side until early December. In Asian markets, The Nikkei Index fell -90 points to 28,140, the Shanghai Index rose 14 points to 3,561 and the Hang Seng Index was closed. In Europe, the German DAX is up over 100 points to 15,250, while the FTSE 100 is slightly lower at 7,120. U.S. stocks ended lower following a choppy session on Tuesday, with investors nervous about upcoming third-quarter earnings reports. In addition to the CPI data, the Federal Reserve will release minutes from its last policy meeting, and investors are looking for further clues on when the central bank could begin tapering its bond-buying program. Market Closing Prices Yesterday The S&P 500 Index dropped -10.54 points, or 0.24%, to 4,350.65 The Dow Jones Industrial Average fell -117.72 points, or 0.34%, to 34,378.34 The Nasdaq Composite slipped -20.28 points, or 0.14%, to 14,465.92 The Russell 2000 Index advanced 13.63 points, or 0.61% to 2,234.27 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 8:30 AM ET Consumer Price Index (CPI) Headline MoM for September…est. +0.3% 8:30 AM ET CPI Core: Ex Food & Energy MoM for September…est. +0.2% 8:30 AM ET Consumer Price Index (CPI) Headline YoY for September…est. +5.3% 8:30 AM ET CPI Core: Ex Food & Energy YoY for September…est.+4.0% 10:30 AM ET Weekly DOE Inventory Data 4:30 PM ET API Weekly Inventory Data Earnings Calendar: Earnings Before the Open: AYR, BLK, DAL, JPM, SOTK Earnings After the Close: ETWO, ODC Other Key Events: China CPI, PPO for September Macro Up/Down Last Nymex -0.56 80.08 Brent -0.60 82.82 Gold 11.60 1,772.80 EUR/USD 0.0034 1.1562 JPY/USD -0.04 113.56 10-Year Note -0.015 1.565% World News China September exports rose1% from last year as consumer demand outpace supply chain disruptions and power shortages Japanese Core Machine Orders (M/M) Aug: -2.4% (exp 1.4%; previous 0.9%); Core Machine Orders (Y/Y) Aug: 17.0% (exp 13.9%; previous 11.1%) The House on Tuesday voted along party lines to raise the U.S. borrowing limit into December, as Democratic lawmakers wrestled with how to set a new ceiling for U.S. debt later this year over Republican resistance. Sector News Breakdown Consumer Duckhorn Portfolio Inc ($NAPA) said selling stockholders are offering 12 mln shares of common stock Monster Beverage ($MNST) downgraded to Hold from Buy at Jefferies Energy, Industrials and Materials International Paper ($IP) announces up to $2B share repurchase program Boeing ($BA) is the latest federal contractor to mandate COVID-19 vaccinations for all employees by December 8 under the Biden administration’s new rules saying its 125K U.S. employees must show proof of vaccination or have an approved religious or medical exemption by the deadline. Yesterday, Chicago soybean futures fell to the lowest level in nearly a year following a U.S. Department of Agriculture report that showed larger than expected yields of soybeans and corn; the USDA showed an uptick of nearly 100M bushels to U.S. corn ending stocks Glencore Plc ($GLNCY) said that it had reached an agreement to sell its zinc business in Bolivia to Canada’s Santa Cruz Silver Mining for some $110M Rattler Midstream LP ($RTLR), a subsidiary of Diamondback Energy, Inc. (FANG) announces strategic midland basin gas gathering & processing joint venture; invested approximately $104 mln in cash to acquire a minority interest in joint venture Vistra ($VST) announces $2 billion share repurchase program Gran Tierra Energy Inc. ($GTE) said that Q3 production grew 53% and that it expects the gains to continue in Q4; said it has produced an average of 28,957 barrels of oil a day in the quarter, compared with 18,944 barrels a day in the prior year period and 23,035 barrels a day QoQ Greenbrier ($GBX) announced the acquisition of more than 3,600 railcars, a portion of which will be held in GBX Leasing Financials BlackRock ($BLK) Q3 adj EPS $10.95 vs. est. $9.35; Q3 revs $5.05B vs. est. $4.9B; qtrly long-term net inflows of $98 billion; assets under management at qtr-end were $9.46 trillion vs $7.81 trillion at end of Q3 AvidXchange ($AVDX)64M share IPO price $25.00 AllianceBernstein L.P. ($AB) preliminary assets under management decreased to $742 billion during September 2021 from $761B at the end of August. Firmwide net inflows were outweighed by market depreciation, resulting in a 2% decline in AUM. In the month of September, net inflows to Retail and Private Wealth were partially offset by net outflows from Institutions. Ellington Financial Inc ($EFC) commenced an underwritten public offering of 5 mln shares of common stock RenaissanceRe Holdings Ltd. ($RNR) estimates that losses from certain 2021 catastrophe events will have a net negative impact of approximately $725 million on the Company’s Q3 results of operations Manning & Napier ($MN) preliminary assets under management (AUM) of $22B for September, compared with $22.7B as of Aug.31. Healthcare Sarepta ($SRPT) announces $500M common stock offering and guiding Q3 revs about $166.9M vs. est. $172M; had approximately $1.6 bln in cash, cash equivalents and investments as of September 30, 2021 CRISPR Therapeutics ($CRSP) shares slipped after announcing updated results from the company’s early-stage trial of its CAR-T cell therapy CTX110 as two patients in the phase 1 trial experienced Grade 3 or higher infections, with one patient having HHV-6 encephalitis, and another developing pseudomonal sepsis that resolved in four days. CytoSorbents ($CTSO) receives full FDA investigational device exemption approval to begin U.S. star-d trial on apixaban and rivaroxaban removal by the DrugSorb-ATR™ antithrombotic removal system during urgent cardiothoracic surgery Homology Medicines ($FIXX) announced the pheEDIT Phase 1 clinical trial for HMI-103, a one-time, in vivo product candidate that utilizes a gene editing approach for phenylketonuria, or PKU, based on the investigational new drug application, or IND, clearance from the FDA Apollo EndoSurgery ($APEN)4M share Spot Secondary priced at $7.75 Bicycle Therapeutics ($BCYC)24M share Secondary priced at $54.00 Relay Therapeutics ($RLAY)21M share Secondary priced at $26.50 Biogen ($BIIB) announces results of a new analysis of immune response to the COVID-19 vaccine among people with multiple sclerosis (MS). Teva Pharmaceuticals Europe BV, a European affiliate of Teva ($TEVA) presents new analyses of the COBRA study, which concluded no evidence was found to suggest that infants were adversely affected by maternal exposure to glatiramer acetate (GA) during pregnancy and breastfeeding with use of COPAXONE Technology, Media & Telecom Apple ($AAPL) suppliers Broadcom ($AVGO), Texas Instruments ($TXN) struggling to deliver enough chips; Apple expects to make 10 million fewer iPhone than planned and is poised to slash iPhone production goal due to chip crunch – Bloomberg (watch shares of $AAPL suppliers including $CRUS, $QRVO, $STM, $AVGO, $SWKS) SAP AG ($SAP) raised its 2021 projections for non-IFRS cloud revenue at constant currencies to range from EUR9.4B to EUR9.6B, up from its earlier view of EUR9.3 billion and EUR9.5 billion; also boosts cloud and software revenue at constant currencies view to EUR23.8 billion to EUR24.2 billion from its earlier view of EUR23.6 billion to EUR24 billion. Qualcomm ($QCOM) announces new $10.0 billion stock repurchase authorization IAC Inc. ($IAC) reports September Angi Inc. total revenue up 18% from last year with Dotdash revenue up 25%, and its Search business revenue up 74% from last year and Emerging & Other revenue was up 33% from last year Vimeo Inc ($VMEO) total revenue for September 2021 up 33%; subscribers for September 2021 up 14%; ARPU for September 2021 up 16% Smart Global Holding ($SGH) Q4 adj EPS $2.16 vs. est. $1.60; Q4 revs $467.7M vs. est. $461.3M; sees Q1 adj EPS $1.80-$2.20 vs. est. $1.49; sees Q1 revenue $440M-$480M vs. est. $458.55M; GAAP gross margin of 25.2%, up 620 basis points versus the year ago quarter and non-GAAP gross margin of 26.4%, up 690 basis points versus the year ago quarter VOXX International ($VOXX) 2Q EPS $0.01 vs est. $0.07 on sales $143.1Mm vs est. $134.4Mm

Wednesday, June 23, 2021 Futures Up/Down % Last Dow 50.00 0.15% 33,885 S&P 500 2.50 0.06% 4,239 Nasdaq 14.75 0.10% 14,273 Markets are looking modestly higher in the U.S., tracking gains in Europe and Asia as investors appear at ease over the inflation picture after Federal Reserve Chairman Powell reiterated yesterday in testimony to Congress that a spike in inflation likely was temporary, easing worries that the central bank could pull back on economic support. Stocks closed higher on Tuesday as the Nasdaq posted a record closing high, boosted by shares of large cap tech as Amazon, Microsoft, and Apple paced the gains in a further rotation into growth stocks. Amazon produced over $5.6 billion in total online sales in the United States on the first day of its Prime promotional event, according to Adobe Digital Economy Index. Helping boost markets further, Federal Reserve Chair Jerome Powell reaffirmed the U.S. central bank’s view during his testimony to Congress on the U.S. economy to not to raise interest rates too quickly based on the fear of coming inflation. Most of the 11 major S&P sector indexes rose, with consumer discretionary and energy among the biggest gainers, erasing most of last week’s market declines. In Asian markets, The Nikkei Index slipped -9 points to 28,874, the Shanghai Index rose 8 points to 3,566, and the Hang Seng Index jumped 507 points to 28,817. In Europe, the German DAX is down -75 points to 15,560, while the FTSE 100 is up 20 points to 7,110. Oil rises back above $75 as API weekly data shows stockpiles drop/shows tight market; Bitcoin rebounds 7% to $34,000, a more than $5,000 move off yesterday lows, having plunged more than 50% from its all-time highs above $65,000 in mid-April; Treasury yields remains little changed/tight range as 10-year at 1.475%. Market Closing Prices Yesterday The S&P 500 Index gained 21.65 points, or 0.51%, to 4,246.44 The Dow Jones Industrial Average rose 68.61 points, or 0.20%, to 33,945.58 The Nasdaq Composite jumped 111.79 points, or 0.79%, to 14,253.27 The Russell 2000 Index advanced 111.79 points, or 0.43% to 2,295.95 Events Calendar for Today 7:00 AM ET MBA Mortgage Applications Data 9:45 AM ET Markit Composite flash PMI, June 9:45 AM ET Markit Manufacturing Services PMI, June…est. 61.5 10:00 AM ET New Home Sales MoM for May…est. 870K 10:30 AM ET Weekly DOE Inventory Data Earnings Calendar: Earnings Before the Open: $PDCO, $WGO Earnings After the Close: $CNXC, $FUL, $KBH, $SCS Other Key Events: BMO Capital 2021 Chemical & Packaging Conference (virtual), 6/23 Goldman Sachs 17th Business Services, Transport & Leisure Conference (virtual), 6/21-6/23 Raymond James Human Health Innovation Conference (virtual), 6/21-6/23 Roth London Conference (virtual), 6/21-6/23 Jefferies Consumer Conference (virtual), 6/22-6/23 JPMorgan 2021 Energy, Power & Renewables Conference (virtual), 6/22-6/23 JPMorgan Payment & FinTech Forum (virtual), 6/23-6/24 Sidoti Investor Conference (virtual), 6/23-6/24 Macro Up/Down Last Nymex 0.45 73.30 Brent 0.55 75.36 Gold 4.30 1,783.005 EUR/USD 0.0006 1.1946 JPY/USD 0.34 110.99 10-Year Note +0.003 1.475% Sector News Breakdown Consumer Xpeng ($XPEV) shares rise upon on receiving approval to list on Hong Kong stock exchange; the company could raise as much as $2B in Hong Kong as soon as this year Energy, Industrials and Materials The American Petroleum Institute ($API) showed a draw of 7.2M barrels of oil in the latest week, gasoline inventories show a build of 959K barrels, distillate inventories show a build of 992K barrels and Cushing inventories show a draw of 2.55M barrels. Clean Energy Fuels ($CLNE) said it contributed $50M to its 50-50 joint venture with BP Plc ($BP) and forced the conversion of BP’s Class B units into Class A units. Parker-Hannifin (PH) upgraded to Overweight from Sector Weight at KeyBanc United Rentals ($URI) upgraded to Buy from Neutral at Citi Financials IHS Markit ($INFO) Q2 adj EPS 81c vs. est. 80c; Q2 revs $1.18B vs. est. $1.13B; raises FY21 adjusted EPS view to $3.15-$3.17 from $3.11-$3.16 (est. $3.16), ups FY21 revenue view to $4.635B-$4.675B from $4.535B-$4.635B (est. $4.6B) and boosts FY21 adj EBITDA view to $2.02B-$2.03B from $2B-$2.03B Global Self Storage ($SELF)12M share Spot Secondary priced at $5.35 Intercontinental Exchange ($ICE) upgraded to Conviction Buy from Buy at Goldman Sachs LPL Financial ($LPLA) downgraded to Buy from Conviction Buy at Goldman Sachs Healthcare BioXcel Therapeutics Inc ($BTAI) launches $100M stock offering with $15M overallotment option on behalf of related stockholder Enanta Pharmaceuticals ($ENTA) says announced positive data from the first two dose cohorts of its Phase 1b study of EDP-514 in viremic chronic HBV patients who were not being treated with a nucleoside reverse transcriptase inhibitor Gemini Therapeutics ($GMTX) announces initial data from its ongoing phase 2a study of gem103 in patients with geographic atrophy secondary to dry age-related macular degeneration GlaxoSmithKline PLC ($GSK) said that it expects growth in sales and adjusted operating profit over the next five years to be underpinned by new vaccines and specialty medicines, as it set targets for the medium and l-t following planned 2022 demerger of its consumer healthcare business. Hologic ($HOLX) has received CE mark for its new Aptima CMV Quant assay in Europe, the company announced United Therapeutics Corp. ($UTHR) and Medtronic Inc. ($MDT) have agreed to stop further efforts to develop and commercialize the implantable system for Remodulin, or ISR; the companies plan to wind down the development program and to support patients already enrolled in clinical studies of the ISR at United Therapeutics’ sole expense Second Sight ($EYES) 10M share Spot Secondary priced at $5.00 Teva Pharmaceuticals ($TEVA) announced its U.S. launch of the first generic version of twice daily PERFOROMIST, formoterol fumarate inhalation solution, 20 mcg/2 ML, indicated to treat bronchoconstriction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema Technology, Media & Telecom Intel Corp. ($INTC) said it would create two new business units that would focus separately on software and high-performance computing and graphics; also said current executives Sandra Rivera and Raja Koduri will take on new senior leadership roles, while technology industry veterans Nick McKeown and Greg Lavender will join Intel. Corning ($GLW) said midday yesterday it is increasing its display glass substrate prices for Q3 “moderately” due to higher logistics and materials costs and other operational expenses during the extended glass shortage Bentley Systems ($BSY) announces offering of $500M of convertible senior notes Sprinklr ($CXM)625M share IPO priced at $16.00

/*============================================= = Friday, June 11, 2021 = =============================================*/ Futures Up/Down % Last Dow 75.00 0.22% 34,429 S&P 500 4.25 0.11% 4,233 Nasdaq 13.50 0.09% 13,963 Stock futures are looking higher, trying to build off yesterday’s gains as the S&P 500 Index posted its first closing high in over a month and as the Nasdaq Composite outperformed (rising over 0.75%) as the yield on the benchmark 10-year yield fell to its lowest levels since March, now down around the 1.43% level. Market fears of rising prices and inflation have deteriorated despite another spike in CPI yesterday when prices topped 5% on YoY basis, its highest levels since 2008 as investors hang on to the notion (implied by the Fed) that the price hikes are indeed transitory. Market gains were paced by strong gain in healthcare and REITs. In Asian markets, The Nikkei Index fell -9 points to 28,948, the Shanghai Index slid -21 points to 3,589, and the Hang Seng Index rose 103 points to 28,842. In Europe, the German DAX is up about 40 points to 15,610, while the FTSE 100 is higher by 45 points to 7,133. Market Closing Prices Yesterday The S&P 500 Index gained 19.63 points, or 0.47%, to 4,239.18 The Dow Jones Industrial Average rose 19.10 points, or 0.06%, to 34,466.24 The Nasdaq Composite jumped 108.58 points, or 0.78%, to 14,020.33 The Russell 2000 Index declined -15.72 points, or 0.68% to 2,311.41 Events Calendar for Today 10:00 AM EST University of Michigan Sentiment June-P 1:00 PM EST Baker Hughes Weekly rig count data Other Key Events: FBN Securities Silicon Valley Tech Tour (virtual), 6/10-6/11 Oppenheimer Virtual Software & Semiconductor Bus Tour, 6/7-6/11 Macro Up/Down Last Nymex 0.13 70.42 Brent 0.14 72.66 Gold -6.00 1,892.50 EUR/USD -0.0014 1.2156 JPY/USD 0.16 109.49 10-Year Note -0.021 1.437% World News The U.S. Senate Commerce Committee unveiled on Thursday a bipartisan surface transportation bill that would authorize $78 billion over five years, including sharply higher passenger rail funding, along with tougher auto safety requirements. Ten Senate Democrats and Republicans say they reached five-year, nearly $1 trillion infrastructure deal ‘; agreement calls for about $974 bln in infrastructure spending over five years without raising taxes. The package includes about $579 bln in new spending. UK Apr GDP beat m/m: 2.3% m/m vs 2.2% cons; 3m/3m 1.5% in-line; y/y 27.6% in-line; UK April Trade Balance smaller deficit: -£10.96b vs -£12.1b consensus; UK Apr Trade Balance non-EU smaller deficit: -£5.55b vs -£6.54b previous Sector News Breakdown Consumer Chewy ($CHWY) 1Q EPS $0.09 vs. est. ($0.03) on sales $2.14B vs. est. $2.13B; Gross margin of 27.6% expanded 420 bps YoY; net margin of 1.8% improved 480 bps YoY; Q1 adjusted EBITDA of $77.4M; Q1 active customers 19.8M, up 31.6% from last year Dave & Busters ($PLAY) Q1 EPS $0.40 vs. est. loss (-$0.19); Q1 revs $265.3M vs. est. $256.6M; Q1 comp store sales fell -35%; sees Q2 revs $335M-$350M vs. est. $287.4M Copa Holdings ($CPA) reports revenue passenger miles dropped 58% to 753.6M in May 2021 vs. May 2019; capacity down 53.4% to 970.9M available seat miles as compared to May 2019 Energy, Industrials and Materials The IEA forecasts global oil demand to recover to pre-pandemic levels late next year and urged OPEC and its allies to keep markets balanced by tapping their plentiful spare production capacity Livent ($LTHM) 13M share Secondary priced at $17.50 REV Group ($REVG)5M share Secondary priced at $15.50 Navigator Holdings ($NVGS) Q1 EPS $0.05 vs. est. $0.05; Q1 revs $85.7M vs. est. $71.29M Financials AGNC Investment ($AGNC) estimates tangible net book value per share of $16.82 as of May 31, 2021, down 6.4% from $17.96 it estimated at April 30. Agree Realty ($ADC) 4M share Spot Secondary priced at $71.50 Manning & Napier ($MN) reports preliminary AUM $22.1B as of May 31 Victory Capital Holdings, Inc. ($VCTR) reported assets under management (AUM) of $160.9 billion as of May 31, 2021 TaskUs ($TASK)2M share IPO priced at $23.00 Healthcare Vertex Pharma ($VRTX) shares declined over 10% after abandoning further development of VX-864 for alpha-1 antitrypsin deficiency saying that the treatment benefit seen in a phase 2 study is “unlikely to translate into substantial clinical benefit.” Jury selection began this week in a case considered one of the biggest and most complicated in the effort to hold corporations liable for the opioid crisis according to Barron’s. The trial, in New York, was delayed a year because of the pandemic. New York state and two of its counties, Nassau and Suffolk on Long Island, are suing a number of companies, including Johnson & Johnson (JNJ), McKesson ($MCK) and Teva Pharmaceutical ($TEVA), for monetary damages Tyme Technologies, Inc. ($TYME) completes strategic review, announces oasis breast trial with Georgetown University, and reports fiscal year 2021 financial results; review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas CureVac ($CVAC) slides; The efficacy of CureVac’s Covid-19 vaccine is still hard to determine but is set to remain in focus as critical data from the phase 3 trial is expected this month, Berenberg says. Analysts at the bank say the trial’s progress seems encouraging and could facilitate a rapid regulatory discussion in the coming months. They expect the CVnCoV vaccine to be 70% to 80% effective – DJ PTC Therapeutics ($PTCT) announced interim results from the ongoing RAINBOWFISH trial that demonstrated pre-symptomatic infants with spinal muscular atrophy, or SMA Vertex Pharmaceuticals ($VRTX) and CRISPR Therapeutics ($CRSP) announce new data on 22 patients, with follow-up of at least 3 months, treated with CRISPR/Cas9-based gene-editing therapy, CTX001 Technology, Media & Telecom Nvidia ($NVDA) has agreed to acquire DeepMap, a startup committed to building high-definition maps for autonomous vehicles to navigate the world safely Didi Chuxing, China’s biggest ride-hailing firm, made public the filing for its long-anticipated U.S. stock market listing, setting the stage for what is expected to be the world’s biggest initial public offering this year. SeaChange ($SEAC) 1Q adj EPS ($0.07) vs. est. ($0.09) on revs $5.1Mm vs. est. $4.9Mm; qtr end backlog $20.1Mm

/*============================================= = MORNING UPDATE - Thursday 05/27/21 = =============================================*/ Futures Up/Down % Last Dow -9.00 0.03% 34,271 S&P 500 -8.25 0.20% 4,184 Nasdaq -54.50 0.40% 13,646 Stock futures are edging slightly lower ahead of a busy morning of economic data, as investors await monthly GDP (2nd estimate for Q1 with estimate about 6.4% – in-line with prior reading), jobless claims data, durable goods and pending home sales. The narrative remains the same day after day as the U.S. economy continues to show improvement/rebound from pandemic lows, which has raised concerns over rising inflation and fears the Fed could pull back on its asset purchases/monetary policy – but most official have said over the last week they don’t feel it will be necessary to change course since rising price pressures likely will just be transitory. Market fears remain non-existent again as the CBOE Volatility Index (VIX) comes into the day below the 18 level (was above 27 just over a week ago). In Asian markets, The Nikkei Index fell -93 points to 28,549, the Shanghai Index rose 15 points to 3,608 and the Hang Seng Index fell -52 points to 29,113. In Europe, the German DAX is down over 40 points to 15,400, while the FTSE 100 is down a few points to 7,015. Stocks edged higher on Wednesday, with the SmallCap Russell 2000 index leading (up nearly 2%), and the tech heavy Nasdaq Composite, as markets were once again spurred by further reassuring talk from Federal Reserve officials that spiking inflation will be “transitory” with Treasury yields remaining lower. Fed Vice Chair Randal Quarles was the latest Fed official to ease worries about inflation. Outside of SmallCap and tech, momentum related sectors fueled the rally with social media “meme” stocks surging ($GME, $AMC, $EXPR, $KOSS), along with electric vehicle names and Bitcoin leveraged stocks. Events Calendar for Today 8:30 AM EST Gross Domestic Product (GDP) Q1 (2nd) …est. 6.5% 8:30 AM EST GDP Price Deflator Q1 (2nd) …est. 4.1% 8:30 AM EST GDP Consumer Spending for Q1 (2nd) 8:30 AM EST Core PCE Prices for Q1…est. 2.3% 8:30 AM EST PCE Prices Prelim for Q1 8:30 AM EST Weekly Jobless Claims…est. 425K 8:30 AM EST Continuing Claims…est. 3.68M 8:30 AM EST Durable Goods for April…est. 0.7% 8:30 AM EST Durable Goods Ex Transports for April…est. 0.8% 10:00 AM EST Pending Home Sales MoM for April…est. 0.8% 10:30 AM ET Weekly EIA Natural Gas Inventory Data 11:00 AM EST Kansas City Fed Manufacturing for May Earnings Calendar: Earnings Before the Open: $AMWD, $BBY, $BURL, $DG, $DLTR, $DXLG, $GCO, $HLNE, $MOV, $PLAN, $SAFM, $TITN Earnings After the Close: $ADSK, $BOX, $COST, $CRM, $DELL, $DOMO, $GPQ, $HPQ, $KRT, $LGF.A, $OLLI, $ULTA, $VEEV, $VMX, $YEXT Other Key Events: Goldman Sachs TechNet Conference Asia Pacific 2021 (virtual), 5/24-5/28 Microsoft Build Conference (virtual), 5/25-5/27 New Relic Future Stack Conference (virtual), 5/25-5/27 UBS Global Oil & Gas Conference (virtual), 5/25-5/27 Wolfe Research Transport & Industrials Conference (virtual), 5/25-5/27 Cowen Digital Dining Summit (virtual), 5/27 Market Closing Prices Yesterday The S&P 500 Index climbed 7.86 points, or 0.19%, to 4,195.99 The Dow Jones Industrial Average rose 10.59 points, or 0.03%, to 34,323.05 The Nasdaq Composite jumped 80.82 points, or 0.59%, to 13,738.00 The Russell 2000 Index surged 43.52 points, or 1.97% to 2,249.27 Macro Up/Down Last Nymex -0.48 65.73 Brent -0.50 68.37 Gold -1.00 1,895.70 EUR/USD 0.0012 1.2204 JPY/USD 0.02 109.17 10-Year Note +0.012 1.586% Sector News Breakdown Consumer American Eagle ($AEO) 1Q adj EPS $0.48 vs. est. $0.46 on revs $1.03B vs. est. $1.02B, says digital momentum continued with revs +57% (Aerie +158%, AE +20%); total inventory +2% vs 2019 Cavaco Industries ($CVCO) Q4 EPS $2.71 vs. est. $1.92; Q4 revs $306.5M vs. est. $293.79M; home sales order rates improved 50% over last year’s quarter; backlogs increased $131M during the quarter; Designer Brands ($DBI) 1Q adj EPS $0.12 vs. est. ($0.18) on sales $703.2Mm vs. est. $651Mm, comps +52.2% Elf Beauty ($ELF) Q4 adj EPS $0.71 vs. est. $0.10; Q4 sales $92.7M vs .est. $82.4M; sees 2022 adj EPS 64c-67c vs. est. 71c and sees year revs $343M-$350M vs. est. $334.3M; Q4 Selling, general and administrative expenses rose 23% to $57.9M Modine Manufacturing ($MOD) Q4 adj EPS $1.14 vs. est. $0.27; Q4 sales $514.9M vs. est. $493M; sees full-year 2022 YoY sales up 12%-18% William-Sonoma ($WSM) Q1 adj EPS $2.93 vs. est. $1.83; Q1 revs $1.75B vs. est. $1.52B; Q1 comp brand revenue growth accelerated to 40.4%, with all brands accelerating sequentially including West Elm at 50.9%, Pottery Barn at 41.3%, Williams Sonoma at 35.3% and Pottery Barn Kids and Teen at 27.6%; raising fiscal year 2021 outlook to low double-digit to mid-teen net revenue growth; for long-term, planning for net rev growth of mid-to-high single digits & non-Gaap operating margin expansion Azek ($AZEK) 15M share Secondary priced at $43.50 Crocs Inc. ($CROX) will replace Cantel Medical Corp. ($CMD) in the S&P MidCap 400, and Organogenesis Holdings Inc. ($ORGO) will take Crocs’ spot in the S&P SmallCap 600 before trading opens on June 2, according to S&P Dow Jones Indices. Energy, Industrials and Materials Vertex Energy ($VTNR) surged after hours after agreeing to acquire the Mobile refinery in Alabama from Royal Dutch Shell (RDS.A) for $75M Ranpak Holdings ($PACK) 5M share Spot Secondary priced at $21.00 The Department of Homeland Security issued a new security directive for pipeline owners and operators on Thursday after a hack of the Colonial Pipeline disrupted fuel supplies in the southeastern United States for days this month Healthcare Change Healthcare ($CHNG) 4Q adj EPS $0.42 vs. est. $0.36 on revs $855.2Mm vs. est. $840.2Mm; says due to recently announced transaction with Optuminsight, will no longer by providing guidance Ironwood Pharmaceuticals ($IRWD) announces agreement with Teva (TEVA) involving Linzess® (linaclotide) 72 mcg dosage strength Myovant Sciences ($MYOV) and Pfizer ($PFE) receive FDA approval for Myfembree®, the first once-daily treatment for heavy menstrual bleeding associated with uterine fibroids Nextgen Healthcare ($NXGN) Q4 adj EPS 21c vs. est. 19c; Q4 revs $144.2M vs. est. $140.1M; sees FY22 adj EPS 89c-95c vs. est. 99c; sees FY22 revs $574M-$584M vs. est. $577.2M; Subscription services revenue in Q4 generated $38.2M, or 16% growth over the prior year period, driven by demand for patient experience-related solutions. Day One ($DAWN) 10M share IPO priced at $16.00 Oak Street Health ($OSH)05M share secondary priced at $62.00 Ocugen ($OCGN) says it is on track to submit emergency use authorization application (EUA) to U.S. FDA for its COVID-19 vaccine, Covaxin, in June; awaiting feedback from FDA after master file regarding vaccine was submitted in March R1 RCM ($RCM) 15M share secondary priced at $22.50 Singular Genomics Systems ($OMIC)2M share IPO priced at $22.00 VIR Biotech ($VIR) received FDA emergency use approval for its antibody treatment co-developed with Glaxo ($GSK) to treat mild-to-moderate COVID-19 in people aged 12 years and older Technology, Media & Telecom NVIDIA ($NVDA) Q1 non-Gaap EPS $3.66 vs. est. $3.28; Q1 revs $5.66B vs. est. $5.41B; qtrly data center revenue of $2.05B, up 79% from a year earlier; Q1gaming revenue of $2.76B, up 106% from a year earlier; sees Q2 revs expected to be $6.30B, plus or minus 2% vs. est. $5.5B; Q2 Gaap and non-Gaap gross margins are expected to be 64.6% and 66.5%, respectively, plus or minus 50 bps after Q1 margins 64.1% vs 65.1% YoY and Q1 non-Gaap gross margin 66.2% vs 65.8% YoY Disneyland ($DIS) to allow non-California guests starting on June 15; Disneyland extends reservation window to 120 days DXC Technology ($DXC) Q4 adj EPS 74c vs. est. 70c; Q4 revs $4.385B vs. est. $4.28B; Q4 bookings were $4.7B; sees FY22 adj EPS $3.45-$3.65 vs. est. $3.44; sees FY22 revenue $16.6B-$16.8B vs. est. $16.91B Nutanix ($NTNX) Q3 adj EPS loss (41c) vs. est. loss (49c); Q3 revs $344.5M vs. est. $334.45M; Q3 billings down 3.2% YoY to $371.1M; guides Q4 ACV billings $170M-$175M and Q4 adjusted gross margin roughly 81.5%-82% Okta Inc. ($OKTA) 1Q adj EPS ($0.10) vs. est. ($0.20) on revs $251Mm vs. est. $238.3Mm; guides 2Q adj EPS loss $0.35-0.36 vs. est. loss $0.11, sees 2Q revs $295-297Mm vs. est. $258.2Mm; guides FY adj EPS loss $1.13-1.16 vs. est. loss $0.44, sees FY revs $1.215-1.225B vs. est. $1.09B; says CFO stepping down June 1st, Brett Tighe (Treasurer) will be interim CFO Ooma Inc. ($OOMA) Q1 EPS $0.11c vs. est. $0.08; Q1 revs $45.6M vs. est. $44.31M; sees Q2 EPS 8c-10c vs. est. 6c; guides Q2 revs $46.0M-$46.8M vs. est. $45.12M; sees FY22 EPS 30c-38c vs. est. 29c; sees year revs $185M-$187M vs. est. $183.64M Pure Storage ($PSTG) Q1 adj EPS 0c vs. est. loss (6c); Q1 revs $412.7M vs. est. $403.91M; sees Q2 revs $470M vs. est. $455.85M; sees Q2 non-GAAP operating income $15M; Q1 Subscription services revenue $162.8 million, up 35% YoY; Q1 GAAP gross margin 68.3%; non-GAAP gross margin 70.5% QAD Inc. ($QADA) 1Q EPS $0.09 vs. est. $0.12 on revs $83Mm vs. est. $78.9Mm, subscription revs $36.7Mm; guides 2Q subscription revs $38.5Mm, maintenance revs $26zmm, sees 2Q op income $1Mm incl stock comp exp $5Mm; guides FY subscription revs $160Mm, maintenance revs $102Mm, op inc $12Mm incl stock comp exp $17Mm Snowflake ($SNOW) 1Q EPS ($0.70) vs. est. ($0.16) on revs $228.9Mm vs. est. $212.9Mm, qtr-end total customers were 4,532; guides 2Q product revs $235-240Mm vs. est. $251Mm; guides FY product revs $1.02-1.04B vs. est. $1.09B Workday ($WDAY) 1Q adj EPS $0.87 vs. est. $0.73 on revs $1.18B vs. est. $1.16B, qtrly subscription revs $1.03B +17%; guides 2Q subscription revs $1.095-1.097B; raises FY subscription revs guide to $4.425-$4.44B, raises FY adj op mgn guide to 18-19%; Zuora ($ZUO) 1Q adj EPS ($0.02) vs. est. ($0.04) on revs $80.3Mm vs. est. $79Mm; guides 2Q adj EPS loss $0.04-0.03 vs. est. loss $0.02, sees 2Q revs $82.5-84.5Mm vs. est. $81.8Mm; guides FY adj EPS loss $0.10-0.06 vs. est. loss $0.08, sees FY revs $337-339Mm vs. est. $336.3Mm FIGS ($FIGS)4M share IPO priced at $22.00 Thryv Holdings ($THRY)24M share Secondary priced at $23.50

Early Look Friday, May 21, 2021 Futures Up/Down % Last Dow 130.00 0.38% 34,158 S&P 500 13.25 0.32% 4,167 Nasdaq 33.00 0.24% 13,519 U.S. stocks are looking higher to end the week, adding to yesterday’s massive gains that saw major averages snap their 3-day losing streak, led by technology shares as Treasury yields remained subdued and on increased economic optimism after Americans filing for first-time unemployment benefits fell last week to a pandemic low of 444,000. It was another “buy the dip” reaction for major averages as the S&P avoided its longest losing streak since February with yesterday’s advance. Oil prices are looking higher, trying to snap its 3-day losing streak, while gold is little changed after a strong week of gains. Inflation fears still linger for markets as pricing fears remain as the economy improves, keeping gains in check for now. The U.S. Treasury, meanwhile, proposed a minimum global corporate tax rate of 15%, lower than earlier proposals of 21% that received pushback from other countries. Crypto currencies are steady after three days of extreme volatility. Yesterday’s big Nasdaq gains (1.77%) gave it a chance to avoid its fifth straight weekly decline heading into the trading week, which would be its longest in nine years (is up 0.8% heading into today). In Asian markets, The Nikkei Index rose 219 points to 28,317, the Shanghai Index slipped -20 points to 3,486, the Hang Seng Index edged higher 8 points to 28,458. In Europe, the German DAX is up about 25 points to 15,394, while the FTSE 100 is little changed at 7,015. Market Closing Prices Yesterday The S&P 500 Index jumped 43.44 points, or 1.06%, to 4,159.12 The Dow Jones Industrial Average rose 188.11 points, or 0.55%, to 34,084.15 The Nasdaq Composite surged 236.00 points, or 1.77%, to 13,535.74 The Russell 2000 Index advanced 14.12 points, or 0.64% to 2,207.76 Events Calendar for Today 9:45 AM EST Markit Composite Flash PMI, May 9:45 AM EST Markit Manufacturing PMI…est. 60.2 9:45 AM EST Markit Services PMI, Flash…est. 64.5 10:00 AM EST Existing Home Sales MoM for April…est. 6.09M 1:00 PM EST Baker Hughes Weekly rig count data Earnings Calendar: Earnings Before the Open: BAH, DE, FL, FLO, ROLL, VFC Other Key Events: UBS Financial Institutions Conference (virtual), 5/19-5/21 Virtual Display Week 2021, 5/17-5/21 Oppenheimer Rare & Orphan Disease Summit (virtual), 5/21 Macro Up/Down Last Nymex 1.01 62.95 Brent 0.93 66.04 Gold 1.75 1,879.00 EUR/USD 0.0004 1.2232 JPY/USD -0.09 108.69 10-Year Note +0.005 1.639% Sector News Breakdown Consumer Home Depot ($HD) announces $20B share buyback Decker’s Outdoors ($DECK) 4Q EPS $1.18 vs. est. $0.64 on sales $561.2Mm vs. est. $437.1Mm; approved additional $750Mm share repurchase auth; guides FY22 net sales $2.95-3.0B vs. est. $2.7B, gross margin approx 53.3%, SG&A exp rt about 35.5%, effective tax rt 23%, EPS $14.05-14.65 excl additional repurchase (vs. est. $14.50); Q4 UGG net sales +53.1%, HOKA net sales +74.2% and Teva net sales +1% Flowers Foods ($FLO) Q1 adj EPS 41c vs. est. 39c; Q1 revs $1.30B vs. est. $1.33B; Q1 adjusted EBITDA decreased 1.0% to $161.6M; adj EBITDA represented 12.4% of sales, a 30-basis point increase; sees year EPS $1.10-$1.17 vs. est. $1.13 on revs $4.23B-$4.3B vs. est. $4.26B Ross Stores ($ROST) 1Q EPS $1.34 vs. est. $0.88 on sales $4.5B vs. est. $3.87B; guides 2Q comps +5-7% and EPS $0.80-0.89 vs. est. $1.04; plans FY comps +7-9% and EPS $3.93-4.20 vs. est. $4.22; announces new $1.5B repurchase program Energy, Industrials and Materials Deere & Co ($DE) Q2 $5.68 vs. est. $5.17 and Q2 sales $12.06B (up from prior year $9.25B); raised its full-year profit forecast and posted a 169% surge in quarterly profit; said it expects to see increased supply-chain pressures through the balance of the year; raises net income for 2021 to be between $5.3B-$5.7B from prior forecast of $4.6B-$5.0B Virgin Galactic ($SPCE) upgraded to Buy from Neutral at UBS with a price target of $36, down from $40 Maxeon Solar ($MAXN) Q1 EPS loss ($1.14) vs. est. loss ($1.48); Q1 revs $165M vs. est. $160.28M; sees Q2 revs $165M-$185M vs. est. $218.6M EnerSys ($ENS) Q4 adj EPS $1.30 vs. est. $1.29; Q4 sales $813.5M vs. est. $801M Financials LPL Financial ($LPLA) reported $1.063T total advisory and brokerage assets at the end of April, indicating a 10.9% increase from March 2021; total net new assets were $73.8B Apollo Investment ($AINV) Q4 Net investment income per share 39c vs. 42c est.; total investment income $50.8M, -29% YoY; net asset value per share $15.88 vs. $15.70 YoY American Homes 4 Rent ($AMH)3M share Spot Secondary priced at $36.75 Healthcare Inspire Medical Systems ($INSP) announced last night Anthem ($ANTM) will provide coverage for the company’s Inspire therapy, effective May 20 Technology, Media & Telecom Applied Materials ($AMAT) 2Q adj EPS $1.63 vs. est. $1.51 on revs $5.58B vs. est. $5.41B; guides 3Q net sales approx $5.92B vs. est. $5.54B, sees 3Q adj EPS $1.70-1.82 vs. est. $1.56 Palo Alto Networks ($PANW) Q3 adj EPS $1.38 vs. est. $1.28; Q3 revs $1.1B vs. est. $1.06B; Q4 Total billings in the range of $1.695B-$1.715B, representing YoY growth of between 22% and 23% (and year total billings growth over 23%); sees Q4 adj EPS $1.42-$1.44 vs. est. $1.42; guides Q4 revs $1.165B-$1.175B vs. est. $1.16B; raises year EPS, revs and billings growth outlook ePlus ($PLUS) 4Q adj EPS $1.41 vs. est. $1.20 on sales $325.6Mm vs. est. $390.8Mm Splunk ($SPLK) upgrade from Sell to Neutral with $125 tgt at UBS saying with shares down 45% since the weak 3QF21/Oct print in early Dec 2020 and given profoundly weak investor sentiment, Splunk shares are looking washed-out and in our view the justification for holding on to our Sell rating has weakened AT&T ($T) upgraded to Buy from Neutral at UBS and raise target to $35 from $32 Yalla Group Limited ($YALA) has authorized a buyback program to repurchase up to $150M (follows three negative short reports in the last two days)

658 $TEVA JAN2022 $12 Cs bought 0.89

658 $TEVA JAN2022 $12 Cs bought 0.89

1999 $TEVA Jan 2022 9.0 Puts trade $0.80 (FT Theo=0.84) ASKSIDE [NOM] 11:03:26 IV=40.7% -1.9 OPENING Post-Earnings Vol=2001, OI=22,

20000 $TEVA JAN2022 $12 / $17 call spreads bought 1.19

20000 $TEVA JAN2022 $12 / $17 call spreads bought 1.19

OPKO Health Takeover Chatter $OPK $TEVA

17468 $TEVA JAN2022 $12 / $17 call spreads bought 1.22

17468 $TEVA JAN2022 $12 / $17 call spreads bought 1.22

2000 $TEVA MAR2021 $14 Cs bought 0.55

2000 $TEVA MAR2021 $14 Cs bought 0.55

3000 $TEVA MAR2021 $14 Cs bought 0.47

3000 $TEVA MAR2021 $14 Cs bought 0.47

Mar $12 > @bunnytoad69 said: or did you just have equity on $TEVA ?

or did you just have equity on $TEVA ? > @bunnytoad69 said: what was your TEVA position again @Dros? Late feb calls? i forget

what was your TEVA position again @Dros? Late feb calls? i forget

@dros are you still in TEVA btw

anyone holding $TEVA

2714 $TEVA FEB2021 $13 Cs bought 0.58

2714 $TEVA FEB2021 $13 Cs bought 0.58

what is the meaning if there is no date ? FEB2021 > @dros said: 1373 $TEVA FEB2021 $13 Cs bought 0.39

1373 $TEVA FEB2021 $13 Cs bought 0.39

1373 $TEVA FEB2021 $13 Cs bought 0.39